Sharon Rbeiz

Sharon Rbeiz is a biotechnology strategy consultant at Rbeiz Bio Consulting, providing commercial and strategic consulting for late clinical stage biotechnology and pharmaceutical companies, with a focus on oncology, immunology, and rare diseases. In addition, Sharon serves as a strategic advisor to Outcomes4Me, where responsibilities include guidance on partnerships with oncology drug developers. Previous experience includes serving as VP at Fulcrum Therapeutics, leading the FTX-6058 program for sickle cell disease, and holding several senior marketing roles at Foundation Medicine, where leadership encompassed new product planning and global market strategies. Additional roles include positions at Vertex Pharmaceuticals, Hill Holliday, Digitas Health LifeBrands, and Genzyme across various capacities in marketing, patient engagement, and account management. Sharon holds a BA in French and Philosophy from Brandeis University.